The Mediating Role of Death Anxiety in Hemodialysis Patients

The Mediating Role of Death Anxiety in the Relationship Between Religious Attitudes and Spiritual Care Needs in Hemodialysis Patients: A Sample of Turkey

This study aimed to determine the mediating role of death anxiety in the relationship between religious attitudes and spiritual care needs of hemodialysis (HD) patients in Turkey. The research was designed as a descriptive and cross-sectional study. A total of 203 patients were included in the study. Descriptive Characteristics Form, Religious Attitude Scale (RAS), Spiritual Care Needs Scale (SCNS), and Death Anxiety Scale (DAS) were used for data collection. In this study, it was found that the indirect effect of religious attitudes on spiritual care needs was significant, and death anxiety mediated the relationship between religious attitudes and spiritual care needs (b= -1.754, 95% CI [-2.95, -0.65]). It can be concluded that death anxiety in HD patients directs individuals towards religious attitudes, and in this case, the need for spiritual care increases. In other words, death anxiety mediates the relationship between religious attitudes and spiritual care needs. Therefore, nurses should include spiritual care when providing nursing care for HD patients.

Study Overview

• Status: Completed
• Conditions: Hemodialysis Complication; Death Anxiety; Religious Stigmata
• Intervention / Treatment: Other: observation

Detailed Description

Materials and Methods The research was designed as a descriptive and cross-sectional study. Population and Sample The population of the study consisted of patients undergoing hemodialysis treatment at Necmettin Erbakan University Medical Faculty Hospital.

Sample The data of Burucu and Cantekin (2022) were used to determine the sample size. In this study, it was reported that death anxiety in dialysis patients varied according to the type of dialysis. In the mentioned study, R2 was 0.062. According to the multiple regression results on death anxiety, it was determined that the study should be completed with at least 149 participants to achieve 80% power and an effect size of 0.066. According to Dunson and Bollen, Structural Equation Modeling can be adequately performed with small sample sizes (approximately 100). However, it is recommended that the sample size should be 200 or more. Therefore, the calculated number was increased by 35% in line with the literature and the sample size of the study was determined as 201. A total of 203 patients were included in the study.

Data Collection Tools Descriptive Characteristics Form, Religious Attitude Scale (RAS), Spiritual Care Needs Scale (SCNS), and Death Anxiety Scale (DAS) were used for data collection.

Data were collected face-to-face by the researchers in the hemodialysis (HD) unit. During data collection, protective measures were taken to prevent the risk of infection. The patients were informed about the study and their consent was obtained.

Ethical approval was obtained from the XXX University Health Sciences Scientific Research Ethics Committee, and necessary permissions were obtained from XXX University Medical Faculty Hospital. All stages of the study were completed in accordance with the STROBE checklist and the Declaration of Helsinki.

• Study Type: Observational
• Enrollment (Actual): 203

Contacts and Locations

Study Locations

• Turkey
  • Meram
    • Konya, Meram, Turkey, 42090
      • Necmettin Erbakan University

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult; Older Adult
• Accepts Healthy Volunteers: N/A

• Sampling Method: Non-Probability Sample

Study Population

The data of Burucu and Cantekin (2022) were used to determine the sample size. In this study, it was reported that death anxiety in dialysis patients varied according to the type of dialysis. In the mentioned study, R2 was 0.062 (Burucu & Cantekin, 2023). According to the multiple regression results on death anxiety, it was determined that the study should be completed with at least 149 participants to achieve 80% power and an effect size of 0.066. According to Dunson and Bollen, Structural Equation Modeling can be adequately performed with small sample sizes (approximately 100) (Palomo, Dunson, & Bollen, 2007). However, it is recommended that the sample size should be 200 or more (Şen & Yılmaz, 2013). Therefore, the calculated number was increased by 35% in line with the literature (Yıldırım Kaptanoğlu, 2013) and the sample size of the study was determined as 201. A total of 203 patients were included in the study.

Description

Inclusion Criteria:

• Being eighteen years of age or older
• Being a resident in Turkey
• To be continuing HD treatment
• Not having communication barriers

Exclusion Criteria:

• Non-Muslim individuals,
• Those who are in the last stage of the disease,
• Those undergoing cancer treatment
• Those with cognitive impairment

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
The mediating role of death anxiety on the impact of religious attitudes on spiritual care needs	It was evaluated whether there is a mediating role of death anxiety on the effect of religious attitudes on spiritual care needs	2.10.2023/30.02.2024

Collaborators and Investigators

• Sponsor: Necmettin Erbakan University

Study record dates

Study Major Dates

• Study Start (Actual): October 2, 2023
• Primary Completion (Actual): February 25, 2024
• Study Completion (Actual): March 15, 2024

Study Registration Dates

• First Submitted: June 22, 2024
• First Submitted That Met QC Criteria: June 22, 2024
• First Posted (Actual): June 27, 2024

Study Record Updates

• Last Update Posted (Actual): July 8, 2024
• Last Update Submitted That Met QC Criteria: July 4, 2024
• Last Verified: July 1, 2024

More Information

Terms related to this study

• Keywords: Hemodialysis; Renal failure; Death anxiety; Religious attitudes; Spiritual Care Needs
• Additional Relevant MeSH Terms: Mental Disorders; Pathologic Processes; Anxiety Disorders; Death
• Other Study ID Numbers: NECMETTİN EU-

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: UNDECIDED

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No